Germline variant burden in multidrug resistance transporters is a therapy‐specific predictor of survival in breast cancer patients is a research paper published in International Journal of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: EXC 2180‐390900677
Horizon 2020 Framework Programme
Grant: 668353
Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
Vetenskapsrådet
Grant: 2016‐01153
Vetenskapsrådet
Grant: 2016‐01154
Swedish Research Council
Grant: unidentified
unidentified
FWCI
1.45
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity
Additional file 1 of The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity